# Armata Pharmaceuticals, Inc.: Form 4, filed Apr 1, 2022

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 4
- Filed: 2022-04-01
- Accepted by EDGAR: Apr 1, 2022, 16:52 ET
- Period: 2022-03-31
- Accession: 0001567619-22-007861
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000156761922007861/xslF345X03/doc1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000156761922007861/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000156761922007861/xslF345X03/doc1.xml

Filed Apr 1, 2022.
Source: SEC EDGAR, the filing index for accession 0001567619-22-007861. Last ingested by Listed: Nov 13, 2026, 16:13 ET. No prices; not investment advice.
